Citadel Advisors’s BioXcel Therapeutics BTAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-3,713
Closed -$22.2K 14525
2024
Q4
$22.2K Buy
3,713
+1,982
+115% +$16.6K ﹤0.01% 13113
2024
Q3
$16.9K Sell
1,731
-2,382
-58% -$32K ﹤0.01% 12909
2024
Q2
$84.2K Sell
4,113
-743
-15% -$24.9K ﹤0.01% 11151
2024
Q1
$219K Sell
4,856
-700
-13% -$33.4K ﹤0.01% 10130
2023
Q4
$262K Sell
5,556
-1,132
-17% -$62.9K ﹤0.01% 9426
2023
Q3
$271K Buy
6,688
+1,282
+24% +$130K ﹤0.01% 9347
2023
Q2
$576K Buy
5,406
+4,525
+514% +$1.51M ﹤0.01% 7629
2023
Q1
$263K Sell
881
-557
-39% -$238K ﹤0.01% 9649
2022
Q4
$494K Buy
1,438
+188
+15% +$45.5K ﹤0.01% 8266
2022
Q3
$236K Sell
1,250
-1,381
-52% -$321K ﹤0.01% 10069
2022
Q2
$556K Buy
2,631
+350
+15% +$73.6K ﹤0.01% 8413
2022
Q1
$763K Sell
2,281
-1,769
-44% -$513K ﹤0.01% 8351
2021
Q4
$1.32M Buy
4,050
+131
+3% +$56.2K ﹤0.01% 7220
2021
Q3
$1.9M Sell
3,919
-1,169
-23% -$514K ﹤0.01% 6489
2021
Q2
$2.37M Buy
5,088
+1,319
+35% +$719K ﹤0.01% 6182
2021
Q1
$2.6M Buy
3,769
+744
+25% +$599K ﹤0.01% 5775
2020
Q4
$2.24M Buy
3,025
+1,262
+72% +$983K ﹤0.01% 5124
2020
Q3
$1.22M Sell
1,763
-912
-34% -$685K ﹤0.01% 5664
2020
Q2
$2.27M Buy
2,675
+1,681
+169% +$1.1M ﹤0.01% 4343
2020
Q1
$355K Buy
+994
New +$357K ﹤0.01% 7030

Other funds holding BTAI